Isoprene Pharmaceuticals, Inc.
Glen Burnie, MD Isoprene Pharmaceuticals, Inc.
- UEI
- KS62EAD1NHJ7
- CAGE
- 8FJ13
- Primary NAICS
- Not on record
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 7908 Springridge Rd, Glen Burnie, MD 21060, USA
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Development of VNPP433-3BETA as novel therapeutic for all stages of prostrate cancer - project title: development of… | National Cancer Institute | $2,045,044 | |
| Development of vnlg-152R as novel therapeutic for triple negative breast cancer - project title: development of MNK1/2… | National Cancer Institute | $4,975,500 |
Quick answers
What is Isoprene Pharmaceuticals, Inc.'s UEI?
Isoprene Pharmaceuticals, Inc.'s Unique Entity ID (UEI) in SAM.gov is KS62EAD1NHJ7.
What is Isoprene Pharmaceuticals, Inc.'s CAGE code?
Isoprene Pharmaceuticals, Inc.'s CAGE code is 8FJ13.
Where is Isoprene Pharmaceuticals, Inc. located?
Isoprene Pharmaceuticals, Inc.'s physical address in SAM.gov is 7908 Springridge Rd, Glen Burnie, MD 21060, USA.
Is Isoprene Pharmaceuticals, Inc. registered in SAM.gov?
Yes. Isoprene Pharmaceuticals, Inc.'s SAM.gov registration is active through January 5, 2027.
What is Isoprene Pharmaceuticals, Inc.'s most recent federal award?
Isoprene Pharmaceuticals, Inc.'s most recent federal grant award is Development of VNPP433-3BETA as novel therapeutic for all stages of prostrate cancer - project title: development of… (R44CA291285), from National Cancer Institute, on June 4, 2025.
On GovTribe
See Isoprene Pharmaceuticals, Inc.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors